Pop-Crisan, A.; Pirlog, R.; Pruteanu, L.-L.; Busuioc, C.; Pop, O.-L.; Pandey, D.P.; Braicu, C.; Berindan-Neagoe, I.
ATRX, OLIG2, MGMT, and IDH2 in Glioblastoma: Essential Molecular Mechanisms and Therapeutic Significance. Medicina 2025, 61, 697.
https://doi.org/10.3390/medicina61040697
AMA Style
Pop-Crisan A, Pirlog R, Pruteanu L-L, Busuioc C, Pop O-L, Pandey DP, Braicu C, Berindan-Neagoe I.
ATRX, OLIG2, MGMT, and IDH2 in Glioblastoma: Essential Molecular Mechanisms and Therapeutic Significance. Medicina. 2025; 61(4):697.
https://doi.org/10.3390/medicina61040697
Chicago/Turabian Style
Pop-Crisan, Andrea, Radu Pirlog, Lavinia-Lorena Pruteanu, Constantin Busuioc, Ovidiu-Laurean Pop, Deo Prakash Pandey, Cornelia Braicu, and Ioana Berindan-Neagoe.
2025. "ATRX, OLIG2, MGMT, and IDH2 in Glioblastoma: Essential Molecular Mechanisms and Therapeutic Significance" Medicina 61, no. 4: 697.
https://doi.org/10.3390/medicina61040697
APA Style
Pop-Crisan, A., Pirlog, R., Pruteanu, L.-L., Busuioc, C., Pop, O.-L., Pandey, D. P., Braicu, C., & Berindan-Neagoe, I.
(2025). ATRX, OLIG2, MGMT, and IDH2 in Glioblastoma: Essential Molecular Mechanisms and Therapeutic Significance. Medicina, 61(4), 697.
https://doi.org/10.3390/medicina61040697